LBP AM SA

Position in BMY — Bristol Myers Squibb Co

CIK 1970075 Paris, I0

Position in BMY

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$12,020,684

+$1,690,473 QoQ

Shares Held

208,620

+22.5% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#367

of 2,506 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LBP AM SA holds $460,857,557 across 9 Drug Manufacturers - General names. BMY ranks #6 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	164,898	$197,783,623
2	JNJ	Johnson & Johnson	313,735	$79,679,277
3	ABBV	AbbVie Inc.	283,892	$71,438,582
4	MRK	Merck & Co., Inc.	369,803	$47,519,685
5	GILD	Gilead Sciences, Inc.	265,498	$33,543,017
6	BMY	Bristol Myers Squibb Co This page	208,620	$12,020,684
7	PFE	Pfizer Inc	477,573	$11,499,957
8	AMGN	Amgen Inc	10,968	$3,971,732

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,020,684	208,620	+22.5%	Shares	Sole	2026-07-24
2026-03-31	$10,330,211	170,325	-46.4%	Shares	Sole	2026-04-27
2025-12-31	$17,155,401	318,046	-15.1%	Shares	Sole	2026-01-26
2025-09-30	$16,901,630	374,759	-4.0%	Shares	Sole	2025-10-31
2025-06-30	$18,078,050	390,539	-7.8%	Shares	Sole	2025-07-18
2025-03-31	$25,842,621	423,719	-3.5%	Shares	Sole	2025-04-30
2024-12-31	$24,836,570	439,119	+26.0%	Shares	Sole	2025-02-10
2024-09-30	$18,033,097	348,533	+398.7%	Shares	Defined	2024-11-12
2024-06-30	$2,902,490	69,889	+30.6%	Shares	Sole	2024-07-31
2024-03-31	$2,901,630	53,506	-89.3%	Shares	Sole	2024-05-16
2023-12-31	$25,641,915	499,745	-12.8%	Shares	Sole	2024-02-14
2023-09-30	$33,270,095	573,227	+4.3%	Shares	Sole	2023-11-14
2023-06-30	$35,133,426	549,389	+455.9%	Shares	Sole	2023-08-14
2023-03-31	$6,849,560	98,825	-4.4%	Shares	Sole	2023-05-15
2022-12-31	$7,437,831	103,375	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.